✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchMental HealthAnxietyNeurologySafetyPolicyDosing Why This Matters I don't see a summary provided for this article. Could...
GLP-1 Receptor Agonists and Hair Loss: Clinical Evidence
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical ReviewSystematic ReviewHair Loss and AlopeciaSemaglutideEndocrinologyAdults with ObesityAdverse Effect MonitoringTelogen Effluvium MechanismGLP-1...
GLP-1 Weight Loss Drugs: Clinical Evidence Guide
GLP-1 Clinical Relevance #52Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical ReviewSystematic ReviewWeight LossGLP-1 Receptor AgonistFamily MedicineAdults with ObesityWeight Management OutcomesAppetite RegulationMetabolic...
Efficacy of pharmacological treatments for Dravet syndrome: Systematic review and network …
✦ New CED Clinical Relevance #85 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyCBDPediatricsSafety Why This Matters This systematic review and network meta-analysis provides clinicians with evidence-based guidance...
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data interpretation and the extrapolation to chronic pain conditions.
Cannabis Medicines Show Modest Promise for Nerve Pain, But Evidence Remains Inconclusive
CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data interpretation and the extrapolation to chronic pain conditions.
From Analgesia to Synaptic Remodeling: A Systematic Review of Acetaminophen’s Neuromodulatory Effects.
Neuro-related disorders will be rising globally. Current treatments have numerous limitations that can impair patients’ quality of life. One of the key thera…
Development of a Decision Aid to Support Shared Decision-Making on Cannabis Use for Arthritis: Protocol for a Multiphase Study.
Conventional treatments have been frequently reported to offer partial relief for some individuals managing arthritis pain and related symptoms, leading many…
Prevalence of schizophrenia spectrum and bipolar disorder among patients with cannabis induced psychosis: a systematic review and meta-analysis.
Distinguishing cannabis-induced psychosis from primary psychiatric disorders is difficult and has significant clinical and prognostic implications. Current t…
Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta-analysis.
Our primary aim was to conduct a network meta-analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharma…